In this opinion article, the author references a study released earlier in the year led by Dhruv Kazi, MD, MSc, MS (Cardiology, BIDMC) that quantified the effect of the COVID-19 pandemic on the numbers of patients seeking medical attention for select potentially life-threatening diagnoses.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses COVID-19 vaccine development.
Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) was elected to the National Academy of Medicine for being an international leader in virology and immunology, developing novel vaccines and cure strategies for viruses of global importance, including one of the first COVID-19 vaccine candidates, the first Zika virus vaccine, and the first global mosaic HIV-1 vaccine, as well as defining immunotherapeutic HIV-1 cure strategies.
Two of the Boston area’s top experts (and parents) weigh in.
A unique treatment course may have blunted his body’s production of antibodies, scientists warn.
Classrooms have needed better ventilation for years. It took a pandemic to get us to pay attention.
Johnson & Johnson has paused its COVID-19 vaccine trial after an “unexplained illness” of one the participants. The vaccine is currently in development as part of a partnership between Johnson & Johnson and a team led by Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC).
Case of man reinfected with the coronavirus, reported in a Lancet medical journal, joins a number of Covid-19 second-cases world-wide
A recently released review article from researchers at BIDMC showed that COVID-19 results in higher case numbers and mortality rates in men than women.